Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
AA.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.160.13EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.47EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.182EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.218EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.12.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
A.11EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.22 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.128EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.36.33EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.405EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.296EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AC.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
C.27EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.421EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.364EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.82EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.177.61EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.177.47EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.38EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.251EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
A.2.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.2.41EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BN.1.6EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CA.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BN.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BE.8EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.7.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BH.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BL.1.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BS.1.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.7.13.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
DC.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.7.9EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CP.1.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EQ.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JU.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CJ.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BM.1.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
DE.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.1.8EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.19EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.3.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.2.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.1.19EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.7.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.75.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.1.26EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BN.6EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.19EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used